Plunkett Research Online: Ariad Pharmaceuticals Inc

ARIAD PHARMACEUTICALS INC (Subsidiary) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Ariad Pharmaceuticals, Inc. is an oncology company focused on the discovery, development and commercialization of medicines for use in cancer treatment. It has one product on the market: Iclusig (Ponatinib). Iclusig is a tyrosine kinase inhibitor (TKI) that is commercially-approved in the U.S., Eu.....


ARIAD PHARMACEUTICALS INC

Ticker: Subsidiary
Exchange:
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 617 494-0400
Fax: 617 494-8144
Address: 26 Landsdowne St.
Cambridge, MA 02139 United States

Types Of Business
Industry Ranks

Industry NAICS code:
Parent Company: Takeda Pharmaceutical Company Limited

ContactsDescription

Paris PanayiotopoulosCEO/Director/President
Manmeet SoniCFO/Executive VP/Treasurer
See More
Ariad Pharmaceuticals, Inc. is an oncology company focused on the discovery, development and commercialization of medicines for use in cancer treatment. It has one product on the market: Iclusig (Ponatinib). Iclusig is a tyrosine kinase inhibitor (TKI) that is commercially-approved in the U.S., Eu.....See More See More

$USD, In whole numbers 2016201520142013201220112010
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture

Employee benefits include long-term equity, stock options, an employee stock purchase plan, tuition reimbursement, a 401(k), medical and dental coverage, life insurance, short- and long-term disability, long-term care insurance and an employee assistance program.